Results 41 to 50 of about 163,269 (195)

Utility of serum lactate dehydrogenase in the diagnosis of megaloblastic anemia [PDF]

, 2018
Background: Megaloblastc anemia corresponds to severe macrocytic anemia with hypersegmented neutrophils and very high serum Lactate Dehydrogenase (LDH). The present study was undertaken to evaluate the utility of serum LDH and chloroform inhibited serum ...
Jadhav, D. S., Gaikwad, Amrapali L.
core   +1 more source

Identification of megaloblastic anemia cells through the use of image processing techniques [PDF]

, 2018
Objective: Our aim is to show the possibility of using different image processing techniques for blood smear analysis. Also our aim is to determine the sequence of image processing techniques to identify megaloblastic anemia cells.
Babker, A., Lyashenko, V.
core   +4 more sources

Megaloblastic Anemia - 3

, 2014
This image demonstrates hypersegmented neutrophil and oval-macrocytes in megaloblastic anemia shown under 100X ...
Fraser, Marion
core   +1 more source

Etiological Profile of Macrocytic Anemia in Patients Presenting to a Tertiary Care Hospital

Assam Journal of Internal Medicine
Background: Macrocytic anemia is a common hematological finding with a wide range of causes, from nutritional deficiencies to systemic illnesses and bone marrow disorders.
Akhila Nampally, Deme Swaroopa, Adiraju Krishna Prasad   +2 more
doaj   +1 more source

Thiamine-responsive megaloblastic anemia syndrome: A case report

Journal of Diabetology, 2020
Thiamine-responsive megaloblastic anemia (TRMA) syndrome is a rare autosomal recessive disorder characterized by a cardinal triad consisting of megaloblastic anemia, sensorineural deafness, and diabetes mellitus.
Omkar Patil, Karnam Guruswamy Ravikumar, Sundaramoorthy Gopi, Thulasi Raman, Venkatesan Radha, Viswanathan Mohan   +5 more
doaj   +1 more source

Human biomarker navigator

iMeta, EarlyView.
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li, Qian Zhang, Zijie Wang, Zeping Gui, Jing Liu, Jingda Li, Maojun Jiang, Zukang Chang, Qingqing Han, Bendong Yang, Tariq Saeed, Jun Li, Jinghan Jia, Chenghu Song, Tong Shao, Tianhuan Peng, Xueying Zhang, Pingping Guo, Jun Luo, Gangao Yang, Yuan Wan, Gokhan Zengin, Quan Yuan, Lingru Li, Xiaohui Fan, Yang Luo, Lvyun Zhu, Yanfei Zheng, Wenjun Mao, Wenlong Sun   +29 more
wiley   +1 more source

Arrhythmia in thiamine responsive megaloblastic anemia syndrome [PDF]

, 2018
Thiamine responsive megaloblastic anemia syndrome (TRMAS) is a rare, autosomal recessive disorder characterized by megaloblastic anemia, diabetes mellitus, and progressive sensorineural deafness.
Argun, Mustafa, Mustafa Argun, Nihal Hatipoğlu, BAYKAN, Ali, Nazmi Narin, Sahin, Yavuz, HATİPOĞLU, Nihal, NARİN, Nazmi, AKIN, Leyla, Yavuz Şahin, Kurtoglu, Selim, Ali Baykan, Leyla Akın, Selim Kurtoğlu   +13 more
core   +1 more source

Vitamin B12 deficiency in an infant secondary to nutritional deficiency and an inadequate maternal diet

JPGN Reports, EarlyView.
ABSTRACT Vitamin B12 (cobalamin, Cbl) is an essential micronutrient for DNA synthesis and neurological development. Its deficiency in infants, although infrequent in developed countries, can cause megaloblastic anemia, psychomotor delay, and neurological damage that may become irreversible if not treated early.
Sandra Sala‐Lluch, Nerea Mesas‐Vila, Susana Ferrando‐Monleón, Ana Barrés‐Fernández, Cristina Villar‐Vera, José Vicente Arcos‐Machancoses   +5 more
wiley   +1 more source

Megaloblastic Anemia - 2

, 2014
An image from a peripheral blood smear demonstrating oval macrocytes, schistocytes, and tears in megaloblastic ...
Fraser, Marion
core   +1 more source

A novel mutation in the SLC19A2 gene in a Turkish male with thiamine-responsive megaloblastic anemia syndrome

The Turkish Journal of Pediatrics, 2019
Thiamine-responsive megaloblastic anemia (TRMA) is a very rare syndrome characterized by the triad of early onset megaloblastic anemia, sensorineural deafness and diabetes mellitus.
Işık Odaman-Al, Alper Gezdirici, Melek Yıldız, Gizem Ersoy, Gönül Aydoğan, Zafer Şalcıoğlu, Tuba Nur Tahtakesen, Hasan Önal, Banu Küçükemre-Aydın   +8 more
doaj   +1 more source